Loading clinical trials...
Loading clinical trials...
To determine if the addition of AG-013736 to chemotherapy is beneficial in patients with advanced lung cancer who have not been previously treated.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT01717924 · Signet Ring Cell Gastric Adenocarcinoma
NCT07417488 · Colorectal Cancer, Small Bowel Adenocarcinoma
NCT06616155 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, and more
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT07556640 · Gastric Cancer Stage IV, Peritoneal Metastases From Gastric Cancer, and more
Pfizer Investigational Site
Baton Rouge, Louisiana
Pfizer Investigational Site
Pittsfield, Massachusetts
Pfizer Investigational Site
Columbus, Mississippi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions